Form4insider filings, from the source

SEC Form 4 · accession 0001280776-19-000017

IMMUNIC, INC. · IMUX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert A. Ashley
Officer — Chief Scientific Officer, EVP
Period of report
Jan 11, 2019
Accepted (ET)
Jan 14, 2019 · 9:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F1$0.4284Jan 11, 2019D93,377DFeb 8, 2016Mar 31, 2022Common Stock93,3770D
Stock Option (right to buy)F1$0.4284Jan 11, 2019D23,344DApr 25, 2016Apr 24, 2022Common Stock23,3440D
Stock Option (right to buy)F1$8.00Jan 11, 2019D241,670DSep 13, 2016Sep 25, 2022Common Stock241,6700D
Stock Option (right to buy)F1,F2$8.28Jan 11, 2019D75,000D—May 12, 2026Common Stock75,0000D
Stock Option (right to buy)F1,F3$3.20Jan 11, 2019D75,000D—Jun 9, 2027Common Stock75,0000D
Stock Option (right to buy)F1,F4$5.00Jan 11, 2019D75,000D—Jun 8, 2028Common Stock75,0000D
Restricted Stock UnitsF5,F6—Jan 11, 2019A816,634A——Common Stock816,634816,634D

Explanation of responses